| Investors watch earnings filings with particular interest, as changes in a company’s ratios can be a good indication whether a company is on the right track, or headed the wrong way. Biovail Corporation (BVF) is scheduled to release its earnings results Thursday. The company currently has an earnings per share ratio (EPS trailing twelve months) of 1.46 and investors are hoping to see that number grow. Let’s take a look at the performance of the stock since its previous earnings release. Check this out (it's free!): Stocks You Should Be Watching Right Now; How to Make Good Picks
|
| | | | | | | | |
-
Essential Reading for Traders
-
| | |
| | | | | In the past three months, the stock has posted a - .97% loss in terms of stock price. Over the same period, the Drug Delivery industry group has returned a combined -3.19% loss. So the eyes of investors turn to this new round of earnings. Now, good earnings don’t always lead to higher stock prices, but keeping up on earnings is still a vital part of your fundamental stock analysis. Also note that companies often change earnings dates, so you should double-check them often. When looking at earnings, it’s very helpful to see how stocks compare to others in its industry group. And even though two stocks may not be direct competitors, many analysts and institutional investors compare them and evaluate them in comparison to other stocks in their group. BVF is in the Drug Delivery industry group where it competes for investor dollars with companies like Hospira Inc. (HSP), which released its earnings on 10/27 and last reported a 40.23% gain in quarter-over-quarter EPS. Another industry peer, Elan Corp. plc (ELN) released its earnings on 10/21 and last reported a 160.15% gain in QOQ EPS. To better understand how to evaluate earnings announcements and the affect they have on your portfolio, be sure to read Earnings Announcements and EPS. More...
Keep up with us:
| 
